Healthcare
Technology
People

Healthcare
Technology
People

Portfolio
People
News
Stories
About
Fintech Index
FBRI
Jobs

Search for:

Find a portfolio company, person, community initiative, or story

News

Category

Enterprise IT
FinTech
FrontierTech
Health IT/Services
MedTech
Other
Tech
Therapeutics

GlobeNewswire

Precision BioSciences Receives Fast Track Disease Designation from U.S. Food and Drug Administration for PBCAR0191 Investigational Allogeneic CAR T Cell Therapy
August 19, 2020
PR Web

Snapdocs Announces Lender Point of Sale Integration to Streamline Homebuying Experience for Borrowers
August 19, 2020
PR Newswire

Innovent and Lilly Announce Expansion of TYVYT® (Sintilimab Injection) Licensing Agreement
August 18, 2020
Business Wire

Ivenix Features Smart Pump Interoperability with Epic, Advancing Patient Outcomes and Clinical Efficiency
August 18, 2020
Fortune

Carrot Fertility closes $24 million Series B in a sign of the sector’s strength
August 18, 2020
PR Newswire

Buoy Health Selected as Preferred Partner in AI Enhanced Symptom Checker/ Digital Front Door Category by Consortium Health Plans
August 17, 2020
Business News Asia

Bayer and Hua Medicine announce commercialization agreement and strategic partnership for investigational first-in-class novel diabetes treatment dorzagliatin in China
August 17, 2020
GlobeNewswire

Arvelle Announces Partnership with Durbin Across Europe
August 17, 2020
PR Newswire

Buoy Health Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance
August 13, 2020
GlobeNewswire

Recurly Secures Majority Equity Investment From Accel-KKR
August 12, 2020
PR Newswire

Whatfix Simplifies BMC Helix Adoption
August 12, 2020
GlobeNewswire

Beam Therapeutics Announces First Development Candidates for Sickle Cell Disease and Reports Second Quarter 2020 Results
August 12, 2020
PR Newswire

PatientPing and Real Time Medical Systems Join Forces to Prevent High-Risk Patient Readmissions for Post-Acute Care and Skilled Nursing Facilities
August 11, 2020
PR Newswire

Innovent and Lilly Release Clinical Trial Results of Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum Chemotherapy as First-Line Treatment for Nonsquamous NSCLC in an Oral Presentation at IASLC WCLC 2020 Virtual Presidential Symposium
August 8, 2020
GlobeNewswire

Checkmate Pharmaceuticals Announces Pricing of Initial Public Offering
August 7, 2020
Endpoints News

Biogen hands Denali $1B-plus in cash, $1B-plus in milestones to partner on late-stage Parkinson’s drug
August 6, 2020
PR Newswire

Robert Margolis, MD Joins WelbeHealth Board of Directors
August 6, 2020
TheStreet

IPO Launch: Checkmate Pharmaceuticals Proposes $75 Million IPO
August 4, 2020
Fierce Healthcare

Quartet taps SilverCloud Health to broaden access to digital mental health services
August 4, 2020
GlobeNewswire

Coherus BioSciences Appoints Kimberly Tzoumakas, J.D. to Board of Directors
August 3, 2020
GlobeNewswire

Oxford Biomedica Signs Development, Manufacture & License Agreement with Beam Therapeutics Inc., for LentiVector® Platform for Next Generation CAR-T Therapeutics
August 3, 2020
PR Newswire

Innovent Announces First Patient Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody in China
August 2, 2020
Business Wire

SonderMind and Varsity Tutors Team Up to Help Families and Kids with Well-Being During a Disrupted School Year
July 30, 2020
China Knowledge

Eyebright Medical Technology’s IPO debut on SSE STAR Market today
July 29, 2020
GlobeNewswire

Denali Therapeutics Announces Phase 1b Study by Partner Sanofi of RIPK1-Inhibitor DNL758 (SAR443122) in COVID-19 Patients
July 29, 2020
PR Newswire

Avidity Biosciences Appoints Jae Kim, M.D. as Chief Medical Officer
July 28, 2020
Business Wire

Checkmate Pharmaceuticals Granted FDA Fast Track Designation for CMP-001 Combined with PD-1 Blockade in the Treatment of Certain Types of Metastatic or Unresectable Melanoma
July 27, 2020
GlobeNewswire

Acacia Pharma Advances Preparations for US Launch of BARHEMSYS®
July 27, 2020
PR Newswire

Blueprint Medicines Receives Positive CHMP Opinion for Avapritinib for the Treatment of Adults with Unresectable or Metastatic PDGFRA D842V Mutant Gastrointestinal Stromal Tumors
July 24, 2020
Genetic Engineering & Biotechnology News

Orchard Therapeutics Inks Deal for GSK’s Stable Cell Line Technology
July 23, 2020
GlobeNewswire

Adaptimmune Granted Access to PRIority MEdicines (PRIME) Regulatory Support by the European Medicines Agency for ADP-A2M4 for the Treatment of Synovial Sarcoma
July 23, 2020
Business Wire

Xilio Therapeutics Appoints Paul J. Clancy to its Board of Directors
July 23, 2020
GlobeNewswire

Interos and RiskRecon Identify Vulnerable and Hidden Third, Fourth, and Fifth Party Suppliers
July 22, 2020
GlobeNewswire

Ultragenyx Announces U.S. Commercial Launch of Dojolvi™ (triheptanoin), the First FDA-Approved Therapy for the Treatment of Long-chain Fatty Acid Oxidation Disorders
July 22, 2020
GlobeNewswire

Flywire Helps Education Agents and Institutions Streamline International Tuition Payments
July 21, 2020
PR Newswire

Everest Group Recognizes Whatfix as a Leader in Digital Adoption Platforms PEAK Matrix Report 2020
July 21, 2020
GlobeNewswire

Orchard Therapeutics Announces Orphan Drug and Rare Pediatric Disease Designations for OTL-203 for the Treatment of MPS-I
July 21, 2020
Business Wire

SonderMind Announces Therapist Network Expansion in Ohio
July 20, 2020
FierceBiotech

COVID-19 close-up: Nocion CEO Batycky on controlling cough to control spread
July 16, 2020
PR Newswire

Centene and Quartet Health expand partnership nationwide to help ensure members have access to critical behavioral health care during COVID-19 pandemic and beyond
July 16, 2020
FierceBiotech

New Insilico Medicine spinout to tackle longevity, COVID-19
July 15, 2020
PR Newswire

Even Financial Achieves SOC 2 Type I Compliance
July 15, 2020
GlobeNewswire

Orchard Therapeutics Announces Global License Agreements for Stable Cell Line Technology from GSK
July 15, 2020
GlobeNewswire

Acacia Pharma Assigned US License for BYFAVO™ (remimazolam) by Cosmo Pharmaceuticals NV
July 15, 2020
Deal Street Asia

China’s Citrine Medicine closes $80m in Series A Round
July 14, 2020
The Motley Fool

Blueprint Medicines Inks Deal With Roche Worth Up to $1.7 Billion
July 14, 2020
PR Newswire

Protenus Selected as One of the Best Places to Work in Healthcare for Third Consecutive Year
July 14, 2020
GlobeNewswire

Orchard Therapeutics and MolMed Announce Extension of Gene Therapy Manufacturing Collaboration
July 9, 2020
Xconomy

NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep
July 9, 2020
Kyruus

SCL Health Partners with Kyruus to Enhance Consumer and Provider Experience
July 8, 2020
Reuters

Caplin Point Laboratories Unit Signs Pact With Xellia Pharmaceuticals
July 7, 2020
GlobeNewswire

Precision BioSciences Regains Rights to In Vivo Hepatitis B Virus Program
July 6, 2020
GlobeNewswire

Acacia Pharma Announces US FDA Approval of BYFAVO™ (remimazolam) for injection for the Induction and Maintenance of Procedural Sedation
July 2, 2020
Crunchbase

French-American AI Startup Owkin Closes $18M Series A To Make Medical Research More Collaborative
July 1, 2020
PR Newswire

Blueprint Medicines Announces Submission of New Drug Application to FDA for Pralsetinib for the Treatment of Advanced RET Mutant and RET Fusion-Positive Thyroid Cancers
July 1, 2020
Business Wire

Kyruus Obtains AVIA Recognition for Its Enterprise-Wide Patient Access Platform
July 1, 2020
ACN Newswire

Hua Medicine Announces Positive 24-Week Topline Results of Phase III Metformin Combination Trial of Dorzagliatin
July 1, 2020
GlobeNewswire

Ultragenyx Announces U.S. FDA Approval of Dojolvi™ (UX007/triheptanoin), the First FDA-Approved Therapy for the Treatment of Long-chain Fatty Acid Oxidation Disorders
June 30, 2020
Business Wire

Verve Therapeutics Presents New Data in Non-Human Primates Validating Gene Editing as a Treatment Approach for Coronary Heart Disease at the ISSCR 2020 Virtual Annual Meeting
June 27, 2020
GlobeNewswire

Flywire’s New International Payment Plan Options Help Improve Tuition Affordability During COVID-19
June 25, 2020
PR Newswire

OTA Insight shapes the future of real-time market intelligence with Market Insight
June 25, 2020
PR Newswire

PatientPing Launches Route Solution to Guarantee Hospital E-Notifications Condition of Participation Compliance Under CMS’s Interoperability and Patient Access Rule
June 24, 2020
Business Wire

Compass Therapeutics Completes Reverse Merger and Closes $60 Million Private Placement
June 24, 2020
PR Newswire

TraceLink Announces Results from FDA DSCSA Pilot Program
June 23, 2020
PR Newswire

Sana Biotechnology Announces Completion Of Initial Financing
June 23, 2020
GlobeNewswire

Flywire Announces Charitable Foundation to Help Improve Global Equality
June 23, 2020
GlobeNewswire

Snapsheet Streamlines Outdoorsy’s Operations, Supports Growth through Digital Transformation
June 22, 2020
GlobeNewswire

Tempest Therapeutics Announces First Patient Dosed With the Combination of TPST-1120 Plus Nivolumab in a Phase 1 Study in Patients With Advanced Solid Tumors
June 22, 2020
PR Newswire

Innovent Announces the NMPA Granted Marketing Approval for BYVASDA® (Bevacizumab Biosimilar) in China
June 19, 2020
Business Wire

Jackie Schumacher Joins Rallybio to Lead Global Regulatory Affairs
June 19, 2020
PR Newswire

Innovent Announces First Patient Dosed in A Phase 1b/2 Clinical Trial of IBI362, a Dual GLP-1 and Glucagon Receptor Agonist, in China
June 18, 2020
GlobeNewswire

Hua Medicine Successfully Completes SEED (HMM0301), Dorzagliatin’s Phase III Monotherapy Trial
June 18, 2020
GlobeNewswire

Ultragenyx and Kyowa Kirin Announce U.S. FDA Approval of Crysvita® (burosumab) for the Treatment of Tumor-Induced Osteomalacia (TIO)
June 18, 2020
Business Wire

Xilio Therapeutics Appoints Daniel S. Lynch as Chair of Board of Directors
June 17, 2020
GlobeNewswire

Flywire Survey Reveals Consumers Upbeat About Travel Post COVID-19
June 17, 2020
PR Newswire

Avidity Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 16, 2020
GlobeNewswire

Hua Medicine’s Dorzagliatin Demonstrates Improvements in β-Cell Function in Data Presented at the American Diabetes Association’s 80th Scientific Sessions
June 15, 2020
Snapsheet Drives Digital Payments for Clearcover Claimants and Vendors
June 15, 2020
Business Wire

Magenta Therapeutics and Beam Therapeutics Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate (ADC) MGTA-117 as Conditioning Regimen for Base Editing Therapies
June 15, 2020
ExpressPharma

Caplin Steriles gets USFDA approval for Phenylephrine Hydrochloride Injection USP
June 12, 2020
Reuters

Apellis Pharmaceuticals Says Phase 3 Pegasus Study For Pegcetacoplan Met Primary Endpoint For Efficacy
June 12, 2020
FierceBiotech

Biotech Verve banks $63M to move gene-editing heart attack treatment toward clinic
June 11, 2020
Xconomy

Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes
June 11, 2020
PR Newswire

Avidity Biosciences Announces Pricing of Initial Public Offering
June 11, 2020
PR Newswire

Adagene Announces Strategic Collaboration Agreement with Tanabe Research Laboratories
June 10, 2020
Business Wire

Checkmate Pharmaceuticals Secures $85 Million in Series C Financing
June 10, 2020
PR Newswire

PatientPing Secures $60 Million in Series C Funding to Continue Expansion of National Electronic Notifications Network
June 9, 2020
GlobeNewswire

Denali Therapeutics Provides Broad Update on Its RIPK1 Program Partnered With Sanofi
June 9, 2020
GlobeNewswire

Flywire Improves Healthcare Patient Engagement and Affordability During COVID-19
June 9, 2020
PR Newswire

NFlection Therapeutics Launches with $20M Series A Funding to Advance Lead Program in Neurofibromatosis
June 9, 2020

page 1 1
page 2 2
page 3 3
page 4 4
page 5 5
page 6 6
page 7 7
page 8 8
page 9 9
page 10 10
page 11 11
page 12 12
page 13 13
page 14 14
page 15 15
page 16 16
page 17 17
page 18 18
page 19 19
page 20 20

We create and invest in healthcare and technology companies that improve lives all over the world.

Jump to —

Portfolio
People
News
Stories
About
Fintech Index
FBRI
Jobs

Cambridge
1 Main St.
13th Floor
Cambridge, MA 02142
London
33 Foley Street
London, W1W 7TL
San Francisco
140 New Montgomery Street
2nd Floor, Suite A
San Francisco, CA 94105

© 2023
Terms of Use
Privacy Policy
Stay in Touch

The information on these pages is intended solely for the benefit of entrepreneurs seeking venture capital investments. F-Prime is not offering investment advisory services nor is it offering to sell securities. F‑Prime provides advisory services as Impresa Management LLC. The list of portfolio companies includes investments made by Fidelity Ventures and Eight Roads. FBRI is an affiliate of F‑Prime and a subsidiary of FMR LLC.